Favorable preclinical evaluation of CM-2395 supports future phase I trial in schizophrenia Oct. 29, 2009
MedImmune presents monoclonal antibodies for rheumatoid arthritis at ACR scientific meeting Oct. 29, 2009
BAP and PINP identified as bone metabolism biomarkers for monitoring radionuclide cancer therapy Oct. 28, 2009
Bone formation/resorption biomarkers predict response to Re-186 HEDP therapy in prostate cancer Oct. 27, 2009
RSS